Change in sexual activity 12 months after ART initiation among HIV-positive mozambicans

AIDS and Behavior

Volumn 15, Issue 4, 2011, Pages 778-787

  Pearson, Cynthia R ^a   Cassels, Susan ^a   Kurth, Ann E ^a   Montoya, Pablo ^a,b   Micek, Mark A ^a,b   Gloyd, Stephen S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HEALTH ALLIANCE INTERNATIONAL   (United States)

Author keywords

Africa; Antiretroviral therapy (ART); Concurrency; HIV AIDS; Sexual behavior; Unprotected sex

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; DISEASE TRANSMISSION; ETHNOLOGY; FEMALE; FOLLOW UP; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; MOZAMBIQUE; PSYCHOLOGICAL ASPECT; SEXUAL BEHAVIOR; SEXUALITY; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MOZAMBIQUE; RISK-TAKING; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SOCIOECONOMIC FACTORS; TRUTH DISCLOSURE; YOUNG ADULT;

EID: 79959991686     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9852-3     Document Type: Article

References (75)

1. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-60. (Pubitemid 28135961)
2. Colebunders R, Verdonck K, Nachega J, Kothari P. Impact of new developments in antiretroviral treatments on AIDS patient care in resource-poor countries. AIDS Patient Care STDs. 2000; 14:251-7. (Pubitemid 30321655)
3. De Gruttola V, Wulfsohn M, Fischl MA, Tsiatis A. Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr. 1993;6:359-65. (Pubitemid 23112844)
4. Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26: 435-42. (Pubitemid 32489021)
5. Hogg RS, Heath KV, Yip B, Craib KJP, O'Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450-4. (Pubitemid 28082255)
6. Barroso PF, Schechter M, Gupta P, Bressan C, Bomfim A, Harrison LH. Adherence to antiretroviral therapy and persistence of HIV RNA in semen. J Acquir Immune Defic Syndr. 2003;32: 435-40. (Pubitemid 36363159)
7. Cu-Uvin S, Snyder B, Harwell JI, et al. Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months. J Acquir Immune Defic Syndr. 2006;42:584-7. (Pubitemid 44162427)
8. UNAIDS, WHO. 07 AIDS epidemic update. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization (WHO); 2007.
9. Vanable P, Ostrow D, McKirnan D, Taywaditep K, Hope B. Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychol. 2000;19:134-45.
10. Elford J. HIV treatment optimism and high-risk sexual behaviour among gay men: the attributable population risk. AIDS. 2004;18:2216-7. (Pubitemid 39463694)
11. Valdiserri RO. Mapping the roots of HIV/AIDS complacency: implications for program and policy development. AIDS Educ Prev. 2004;16:426-39. (Pubitemid 39431025)
12. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS. 2006;20:85-92. (Pubitemid 41818118)
13. Wood E, Braitstein P, Montanerr JS, et al. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet. 2000;355:2095-100. (Pubitemid 30364657)
14. Das-Douglas M, Chu S, Santos G-M, Scheer S, McFarland W, Vittinghoff E, Colfax G. Decreases in community viral load are associated with a reduction in new HIV diagnoses in San Francisco. Paper # 33. In: 17th conference on retroviruses and opportunistic infections, San Francisco; 16-19 Feb 2010.
15. Montaner J, Wood E, Kerr T, Yip B, Lima V, Shannon K, et al. Association of expanded HAART coverage with a decrease in new HIV diagnoses, particularly among Injection drug users in British Columbia, Canada. Paper 88LB. In: 17th conference on retroviruses and opportunistic infections, San Francisco; 2010.
16. Granich R, Crowley S, Vitoria M, Lo YR, Souteyrand Y, Dye C, et al. Highly active antiretroviral treatment for the prevention of HIV transmission. J Int AIDS Soc. 2010;13:1.
17. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57. Epub 2008 Nov 2027.
18. Blower S, Bodine E, Kahn J, et al. The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS. 2005;19:1-14. (Pubitemid 40111013)
19. CDC. HIV/AIDS surveillance report, 2006, vol 18. Atlanta: U.S. Department of Health and Human Services, CDC; 2008. p. 1-55.
20. Stolte IG, Dukers NH, Geskus RB, Coutinho RA, de Wit JB. Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS. 2004;18:303-9. (Pubitemid 38253454)
21. Rietmeijer CA, Patnaik JL, Judson FN, Douglas JM Jr. Increases in gonorrhea and sexual risk behaviors among men who have sex with men: a 12-year trend analysis at the Denver Metro Health Clinic. Sex Transm Dis. 2003;30:562-7. (Pubitemid 36828980)
22. Stolte IG, Dukers NH, De Wit JB, Fennema JS, Coutinho RA. Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART. Sex Transm Dis. 2001;77:184-6. (Pubitemid 32595739)
23. Klausner JD, Kent CK, Wong W, McCright J, Katz MH. The public health response to epidemic syphilis, San Francisco, 1999-2004. Sex Transm Dis. 2005;32:S11-8. (Pubitemid 41429167)
24. Pearson CR, Kurth AE, Cassels S, Martin DP, Simoni JM, Hoff P, et al. Modeling HIV transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapy. AIDS Care. 2007;19:594-604. (Pubitemid 46763745)
25. Diabate S, Alary M, Koffi CK. Short-term increase in unsafe sexual behaviour after initiation of HAART in Cote d'Ivoire. AIDS. 2008;22:154-6. (Pubitemid 350294892)
26. Eisele TP, Mathews C, Chopra M, Brown L, Silvestre E, Daries V, et al. High levels of risk behavior among people living with HIV Initiating and waiting to start antiretroviral therapy in Cape Town South Africa. AIDS Behav. 2008;12:570-7. (Pubitemid 351873634)
27. McClelland RS, Graham SM, Richardson BA, Peshu N, Masese LN, Wanje GH, et al. Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers. AIDS. 2010;24:891-7.
28. Moatti JP, Prudhomme J, Traore DC, Juillet-Amari A, Akribi HA, Msellati P. Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Cote d'Ivoire. AIDS. 2003;17:S69-77. (Pubitemid 36951672)
29. Bateganya M, Colfax G, Shafer LA, Kityo C, Mugyenyi P, Serwadda D, et al. Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral-naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care STDS. 2005;19:760-8. (Pubitemid 41705172)
30. Eisele TP, Mathews C, Chopra M, Lurie MN, Brown L, Dewing S, et al. Changes in risk behavior among HIV-positive patients during their first year of antiretroviral therapy in Cape Town South Africa. AIDS Behav. 2009;13:1097-105. Epub 2008 Oct 1010.
31. Peltzer K, Ramlagan S. Safer sexual behaviours after 1 year of antiretroviral treatment in KwaZulu-Natal, South Africa: a prospective cohort study. Sex Health. 2010;7:135-41.
32. Kaida A, Gray G, Bastos FI, Andia I, Maier M, McIntyre J, et al. The relationship between HAART use and sexual activity among HIV-positive women of reproductive age in Brazil, South Africa, and Uganda. AIDS Care. 2008;20:21-5. (Pubitemid 351264535)
33. Pearson CR, Micek M, Simoni JM, Matediana E, Martin DP, Gloyd S. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation. J Acquir Immune Defic Syndr. 2006;43:S134-41. (Pubitemid 44885653)
34. Pearson CR, Micek MA, Simoni JM, Hoff PD, Matediana E, Martin DP, et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr. 2007,9:238-44. (Pubitemid 47482621)
35. Kelly JA, Kalichman SC. Reinforcement value of unsafe sex as a predictor of condom use and continued HIV/AIDS risk behavior among gay and bisexual men. Health Psychol. 1998;17: 328-35. (Pubitemid 28345940)
36. Kennedy C, O'Reilly K, Medley A, Sweat M. The impact of HIV treatment on risk behaviour in developing countries: a systematic review. AIDS Care. 2007;19:707-20. (Pubitemid 46944272)
37. Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24:518-29. (Pubitemid 33604361)
38. Holzemer WL, Makoae M, Greeff PS, Dlamini PS, Kohi ML, Chirwa ML, et al. Measuring HIV stigma for PLHAs and nurses over time in five African countries. SAHARA J. 2009;6:76-82.
39. Genberg BL, Hlavka Z, Konda KA, Maman S, Chariyalertsak S, Chingono A, et al. A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med. 2009;68:2279-87.
40. Brown RL, Leonard T, Rounds LA, Papasouliotis O. A two-item screening test for abuse of alcohol and other drug problems. J Fam Pract. 1997;44:151-60. (Pubitemid 27087650)
41. Sullivan P, et al. Reduction of HIV transmission risk and high risk sex while prescribed ART: results from discordant couples in Rwanda and Zambia. In: 16th conference on retroviruses and opportunistic infections, Montreal; 2009.
42. Reynolds S, et al. ART reduced the rate of sexual transmission of HIV among HIV-discordant couples in rural Rakai, Uganda. In: 16th conference on retroviruses and opportunistic infections, Montreal; 2009.
43. Porco TC, Martin JN, Page-Shafer KA, et al. Decline in infectivity following the introduction of highly active antiretroviral therapy. AIDS. 2004;18:81-8. (Pubitemid 38402321)
44. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23:1397-404.
45. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375:2092-8. Epub 2010 May 2026.
46. Lurie M, Rosenthal S, Williams B. Concurrency driving the African HIV epidemics: where is the evidence? Lancet. 2009; 374:1420. author reply 1420-1421.
47. Lurie MN, Rosenthal S. Concurrent partnerships as a driver of the HIV epidemic in sub-Saharan Africa? The evidence is limited. AIDS Behav. 2010;14:17-24; discussion 25-18.
48. Rothenberg R. HIV transmission networks. Curr Opin HIV AIDS. 2009;4:260-5.
49. Helleringer S, Kohler HP, Kalilani-Phiri L. The association of HIV serodiscordance and partnership concurrency in Likoma Island (Malawi). AIDS. 2009;23:1285-7.
50. Mah TL, Halperin DT. Concurrent sexual partnerships and the HIV epidemics in africa: evidence to move forward. AIDS Behav. 2008, Epub ahead of print.
51. Morris M, Goodreau SM, Moody J. Sexual networks, concurrency, and STD/HIV. In: Holmes KK, editor. Sexually transmitted diseases. New York: McGraw-Hill; 2007.
52. Morris M, Kurth AE, Hamilton DT, Moody J, Wakefield S. Concurrent partnerships and HIV prevalence disparities by race: linking science and public health practice. Am J Public Health. 2009;99:1023-31.
53. Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS. 1997;11:641-83.
54. King R, Lifshay J, Nakayiwa S, Katuntu D, Lindkvist P, Bunnell R. The virus stops with me: HIV-infected Ugandans' motivations in preventing HIV transmission. Soc Sci Med. 2009;68:749-57.
55. Kielmann K, Cataldo F. Tracking the rise of the "expert patient" in evolving paradigms of HIV care. AIDS Care. 2010;22:21-8.
56. Atuyambe L, Neema S, Otolok-Tanga E, Wamuyu-Maina G, Kasasa S, Wabwire-Mangen F. The effects of enhanced access to antiretroviral therapy: a qualitative study of community perceptions in Kampala City, Uganda. Afr Health Sci. 2008;8:13-9.
57. McClelland L, Wanje G, Kashonga F, McClelland RS, Kiarie J, Mandaliya K, et al. Understanding the risk context of HIV and sexual behaviour following antiretroviral therapy rollout in a population of high-risk women in Kenya. AIDS Educ Behav. In review.
58. Kurth AE, Martin DP, Golden MG, Weiss N, Heagerty P, Handsfield HH, et al. A comparison of sexually transmitted infection risk reporting in audio computer-assisted self- interviews and clinician interviews. Sex Transm Dis. 2004;31:719-26. (Pubitemid 39557419)
59. Gilbert L, Walker L. 'My biggest fear was that people would reject me once they knew my status': stigma as experienced by patients in an HIV/AIDS clinic in Johannesburg, South Africa. Health Soc Care Community. 2010;18:139-46.
60. Gebrekristos HT, Lurie MN, Mthethwa N, Karim QA. Disclosure of HIV status: experiences of patients enrolled in an integrated TB and HAART pilot programme in South Africa. Afr J AIDS Res. 2009;8:1-6.
61. Myers JJ, Shade SB, Rose CD, Koester K, Maiorana A, Malitz FE, et al. Interventions delivered in clinical settings are effective in reducing risk of HIV transmission among people living with HIV: results from the Health Resources and Services Administration (HRSA)'s Special Projects of National Significance initiative. AIDS Behav. 2010;14:483-92.
62. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292:224-36. (Pubitemid 38918000)
63. Dawson Rose C, Gutin SA, Reyes M. Adapting positive prevention interventions for international settings: applying U.S. evidence to epidemics in developing countries. J Assoc Nurses AIDS Care. 2010;9:9.
64. Bunnell R, Mermin J, De Cock KM. HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA. 2006;296:855-8. (Pubitemid 44223108)
65. Eaton LA, Kalichman SC. Changes in transmission risk behaviors across stages of HIV disease among people living with HIV. J Assoc Nurses AIDS Care. 2009;20:39-49.
66. Richardson JL, Milam JAM, Stoyanoff S, Bolan R, Weiss J, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: a multi-clinic assessment. AIDS. 2004;18:1179-86. (Pubitemid 38738517)
67. Luchters S, Sarna A, Geibel S, Chersich MF, Munyao P, Kaai S, et al. Safer sexual behaviors after 12 months of antiretroviral treatment in Mombasa, Kenya: a prospective cohort. AIDS Patient Care STDS. 2008;22:587-94. (Pubitemid 352040056)
68. Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A. Disclosure experience and associated factors among HIV positive men and women clinical service users in Southwest Ethiopia. BMC Public Health. 2008;8:81.
69. Simbayi LC, Kalichman SC, Strebel A, Cloete A, Henda N, Mqeketo A. Disclosure of HIV status to sex partners and sexual risk behaviours among HIV-positive men and women, Cape Town, South Africa. Sex Transm Infect. 2007;83:29-34. (Pubitemid 46293802)
70. Harding R, Lampe FC, Norwood S, Date HL, Clucas C, Fisher M, et al. Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse. Sex Transm Infect. 2010;15:15.
71. Wong LH, Rooyen HV, Modiba P, Richter L, Gray G, McIntyre JA, et al. Test and tell: correlates and consequences of testing and disclosure of HIV status in South Africa (HPTN 043 Project Accept). J Acquir Immune Defic Syndr. 2009;50: 215-22.
72. Loubiere S, Peretti-Watel P, Boyer S, Blanche J, Abega SC, Spire B. HIV disclosure and unsafe sex among HIV-infected women in Cameroon: results from the ANRS-EVAL study. Soc Sci Med. 2009;69:885-91.
73. King R, Katuntu D, Lifshay J, al. e. Processes and outcomes of HIV serostatus disclosure to sexual partners among people living with HIV in Uganda. AIDS Behav 2008;12:232-243. (Pubitemid 351643041)
74. Sarna A, Chersich MF, Okal J, Luchters SMF, Mandaliya KN, Rutenberg N, et al. Changes in sexual risk taking with antiret-roviral treatment: influence of context and gender norms in Mombasa, Kenya. Cult Health Sex. 2009;11:783-97.
75. Stoneburner RL, Low-Beer D. Population-level HIV declines and behavioral risk avoidance in Uganda. Science. 2004;304:714-8. (Pubitemid 38560873)